Sustained Viral Suppression in HIV-infected Children on Once-daily Lopinavir/Ritonavir in Clinical Practice

Autor: Ivar P. E. Gondrie, Nico G. Hartwig, Linda C. van der Knaap, Petronette van Jaarsveld, Diane E. T. Bastiaans, Eline G. Visser, Pieter L. A. Fraaij, Annemarie M. C. van Rossum, David M. Burger, Gertjan J. Driessen, Ronald de Groot

Publikováno v: Pediatric Infectious Disease Journal, 36, 976-980
Pediatric Infectious Disease Journal, 36, 10, pp. 976-980
Pediatric Infectious Disease Journal, 36(10), 976-980. Lippincott Williams & Wilkins

Contains fulltext : 176929.pdf (Publisher’s version ) (Closed access) BACKGROUND: The use of lopinavir/ritonavir once-daily (LPV/r QD) has not been approved for children. Good short-term clinical, virologic and immunologic outcomes have been observ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8095f7261efc2e333ec29887d5a4f9a7
http://hdl.handle.net/2066/176929